IMMUNOlogical microenvironment in REctal Adenocarcinoma Treatment (IMMUNOREACT 2; NCT04917263): preliminary results on prediction of complete response to neoadjuvant therapy in rectal cancer. Issue 2 (February 2022) - Spolverato, Gaya; Scarpa, Melania; Fassan, Matteo; Chiminazzo, Valentina; Angriman, Imerio; Ruffolo, Cesare; Facci, Luca; Stecca, Tommaso; Massani, Marco; De Simoni, Ottavia; Pilati, Pierluigi; Pirozzolo, Giovanni; et al.